Extrahypothalamic growth-hormone-releasing factor (GRF) secretion is a rare cause of acromegaly: plasma GRF levels in 177 acromegalic patients. 1984

M O Thorner, and L A Frohman, and D A Leong, and J Thominet, and T Downs, and P Hellmann, and J Chitwood, and J M Vaughan, and W Vale

To assess the frequency with which acromegaly is caused by ectopic secretion of GRF, we collected plasma samples from 177 unselected acromegalic patients. The samples together with those of three acromegalic patients with previously diagnosed tumors secreting GRF and of normal subjects were assayed in 3 independent GRF RIAs. Plasma immunoreactive GRF (IR-GRF) levels in normal subjects were either undetectable or detectable at levels up to 62.5 pg/ml. In none of the 177 specimens from acromegalic patients were IR-GRF values detectable in all assays, and in the most sensitive assay, the levels were similar to those in normal subjects, with the highest level measuring 82 pg/ml. In contrast, plasma IR-GRF found in the 3 patients with tumors that secreted GRF ranged from 2.0-24.4 ng/ml. These data suggest that extrahypothalamic GRF secretion is a rare cause of acromegaly. However, it is important that this rare cause of acromegaly be diagnosed before the patient has unnecessary surgery and/or irradiation directed at the pituitary. We recommend that plasma IR-GRF be measured in each new acromegalic patient.

UI MeSH Term Description Entries
D007031 Hypothalamus Ventral part of the DIENCEPHALON extending from the region of the OPTIC CHIASM to the caudal border of the MAMMILLARY BODIES and forming the inferior and lateral walls of the THIRD VENTRICLE. Lamina Terminalis,Preoptico-Hypothalamic Area,Area, Preoptico-Hypothalamic,Areas, Preoptico-Hypothalamic,Preoptico Hypothalamic Area,Preoptico-Hypothalamic Areas
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000172 Acromegaly A condition caused by prolonged exposure to excessive HUMAN GROWTH HORMONE in adults. It is characterized by bony enlargement of the FACE; lower jaw (PROGNATHISM); hands; FEET; HEAD; and THORAX. The most common etiology is a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. (From Joynt, Clinical Neurology, 1992, Ch36, pp79-80) Inappropriate Growth Hormone Secretion Syndrome (Acromegaly),Somatotropin Hypersecretion Syndrome (Acromegaly),Inappropriate GH Secretion Syndrome (Acromegaly),Hypersecretion Syndrome, Somatotropin (Acromegaly),Hypersecretion Syndromes, Somatotropin (Acromegaly),Somatotropin Hypersecretion Syndromes (Acromegaly),Syndrome, Somatotropin Hypersecretion (Acromegaly),Syndromes, Somatotropin Hypersecretion (Acromegaly)
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M O Thorner, and L A Frohman, and D A Leong, and J Thominet, and T Downs, and P Hellmann, and J Chitwood, and J M Vaughan, and W Vale
June 1985, Journal of endocrinological investigation,
M O Thorner, and L A Frohman, and D A Leong, and J Thominet, and T Downs, and P Hellmann, and J Chitwood, and J M Vaughan, and W Vale
January 1984, The Journal of clinical endocrinology and metabolism,
M O Thorner, and L A Frohman, and D A Leong, and J Thominet, and T Downs, and P Hellmann, and J Chitwood, and J M Vaughan, and W Vale
January 1985, Minerva endocrinologica,
M O Thorner, and L A Frohman, and D A Leong, and J Thominet, and T Downs, and P Hellmann, and J Chitwood, and J M Vaughan, and W Vale
February 1985, The Journal of clinical endocrinology and metabolism,
M O Thorner, and L A Frohman, and D A Leong, and J Thominet, and T Downs, and P Hellmann, and J Chitwood, and J M Vaughan, and W Vale
December 1970, Nihon Naibunpi Gakkai zasshi,
M O Thorner, and L A Frohman, and D A Leong, and J Thominet, and T Downs, and P Hellmann, and J Chitwood, and J M Vaughan, and W Vale
May 1988, Medicina clinica,
M O Thorner, and L A Frohman, and D A Leong, and J Thominet, and T Downs, and P Hellmann, and J Chitwood, and J M Vaughan, and W Vale
January 1982, Acta medica Scandinavica,
M O Thorner, and L A Frohman, and D A Leong, and J Thominet, and T Downs, and P Hellmann, and J Chitwood, and J M Vaughan, and W Vale
January 1989, Life sciences,
M O Thorner, and L A Frohman, and D A Leong, and J Thominet, and T Downs, and P Hellmann, and J Chitwood, and J M Vaughan, and W Vale
May 1985, Clinical endocrinology,
M O Thorner, and L A Frohman, and D A Leong, and J Thominet, and T Downs, and P Hellmann, and J Chitwood, and J M Vaughan, and W Vale
August 1985, Acta endocrinologica,
Copied contents to your clipboard!